/PRNewswire/ The "Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,.
Biotech CEO returns to UI roots in aim to revolutionize health care thegazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thegazette.com Daily Mail and Mail on Sunday newspapers.
Appoints Timothy E. Morris, a veteran biotech executive with over 35 years of experience in executive and financial leadership, to Board of DirectorsNames.
Aquestive Therapeutics Strengthens Team to Align with Strategic Focus on Allergy Space streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The market analysis and insights covered in the finest Malabsorption Syndromes market research report offers key statistics on the market status of global and regional manufacturers and is an imperative source of guidance which provides exact direction to the companies and individuals interested in the industry. The.
Press release content from PR Newswire. The AP news staff was not involved in its creation. Windtree Strengthens Its Board by Appointing Three New Directors February 4, 2021 GMT Windtree Therapeutics, Inc. - Striving to deliver hope for a lifetime WARRINGTON, Pa., Feb. 4, 2021 /PRNewswire/ Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced the appointments of Dr. Evan Loh, Ms. Leslie Williams, and Dr. Rob Scott, to its Board of Directors. The appointments are the result of a board composition analysis conducted by the Board, which took into consideration the changing needs of the Company. In connection with the appointments, Mr. John Leone, Mr. Joseph Mahady, and Dr. Brian Schreiber announced their retirement from the Board. Following the changes, the Windtree Board will continue to be comprised of seven directors.
Windtree Strengthens Its Board by Appointing Three New Directors Company welcomes Dr. Evan Loh, Ms. Leslie Williams and Dr. Rob Scott, seasoned executives with deep cardiovascular development and commercial experience News provided by Share this article Share this article WARRINGTON, Pa., Feb. 4, 2021 /PRNewswire/ Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced the appointments of Dr. Evan Loh, Ms. Leslie Williams, and Dr. Rob Scott, to its Board of Directors. The appointments are the result of a board composition analysis conducted by the Board, which took into consideration the changing needs of the Company. In connection with the appointments, Mr. John Leone, Mr. Joseph Mahady, and Dr. Brian Schreiber announced their retirement from the Board. Following the changes, the Windtree Board will continue to be comprised of seven directors.
Global Auto-Immune Diseases Diagnostic Testing Device Pipeline Assessment 2020 - ResearchAndMarkets.com tullahomanews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tullahomanews.com Daily Mail and Mail on Sunday newspapers.